1.38
price down icon0.72%   -0.01
after-market アフターアワーズ: 1.40 0.02 +1.45%
loading
前日終値:
$1.39
開ける:
$1.4
24時間の取引高:
207.10K
Relative Volume:
0.42
時価総額:
$45.30M
収益:
$3.04M
当期純損益:
$-33.97M
株価収益率:
-1.0376
EPS:
-1.33
ネットキャッシュフロー:
$-52.47M
1週間 パフォーマンス:
-6.76%
1か月 パフォーマンス:
-6.76%
6か月 パフォーマンス:
-51.24%
1年 パフォーマンス:
-60.00%
1日の値動き範囲:
Value
$1.35
$1.41
1週間の範囲:
Value
$1.35
$1.52
52週間の値動き範囲:
Value
$1.24
$8.75

Rani Therapeutics Holdings Inc Stock (RANI) Company Profile

Name
名前
Rani Therapeutics Holdings Inc
Name
セクター
Healthcare (1178)
Name
電話
(408) 457-3700
Name
住所
2051 RINGWOOD AVENUE, SAN JOSE
Name
職員
140
Name
Twitter
Name
次回の収益日
2024-11-08
Name
最新のSEC提出書
Name
RANI's Discussions on Twitter

RANI を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
RANI
Rani Therapeutics Holdings Inc
1.38 45.30M 3.04M -33.97M -52.47M -1.33
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
438.40 113.67B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
683.08 74.97B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
665.68 40.50B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
277.16 35.95B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
120.88 29.63B 3.30B -501.07M 1.03B -2.1146

Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-08-02 開始されました Oppenheimer Outperform
2024-06-14 開始されました Maxim Group Buy
2024-06-13 開始されました Rodman & Renshaw Buy
2023-04-17 再開されました BTIG Research Buy
2022-10-11 開始されました UBS Buy
2022-07-27 開始されました H.C. Wainwright Buy
2022-06-13 開始されました Wedbush Outperform
すべてを表示

Rani Therapeutics Holdings Inc (RANI) 最新ニュース

pulisher
Jan 17, 2025

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $11.71 Consensus PT from Brokerages - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $11.71 Consensus Target Price from Analysts - Defense World

Jan 17, 2025
pulisher
Jan 14, 2025

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $11.71 Average Target Price from Brokerages - MarketBeat

Jan 14, 2025
pulisher
Jan 13, 2025

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Shares Purchased by Geode Capital Management LLC - Defense World

Jan 13, 2025
pulisher
Jan 10, 2025

Rani Therapeutics stock hits 52-week low at $1.29 - Investing.com India

Jan 10, 2025
pulisher
Jan 10, 2025

Rani Therapeutics stock hits 52-week low at $1.29 By Investing.com - Investing.com South Africa

Jan 10, 2025
pulisher
Dec 27, 2024

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Shares Acquired by Stifel Financial Corp - Defense World

Dec 27, 2024
pulisher
Dec 23, 2024

Analysts Set Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Target Price at $11.71 - Defense World

Dec 23, 2024
pulisher
Dec 20, 2024

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $11.71 Average PT from Brokerages - MarketBeat

Dec 20, 2024
pulisher
Dec 19, 2024

Rani Therapeutics stock hits 52-week low at $1.32 - Investing.com

Dec 19, 2024
pulisher
Dec 17, 2024

Insider Buying: Kate Mckinley Acquires Shares in Rani Therapeuti - GuruFocus.com

Dec 17, 2024
pulisher
Dec 16, 2024

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Insider Kate Mckinley Acquires 17,960 Shares - MarketBeat

Dec 16, 2024
pulisher
Dec 11, 2024

Rani Therapeutics stock hits 52-week low at $1.85 By Investing.com - Investing.com Nigeria

Dec 11, 2024
pulisher
Dec 11, 2024

Rani Therapeutics stock hits 52-week low at $1.85 - Investing.com India

Dec 11, 2024
pulisher
Dec 10, 2024

CEO Talat Imran Acquires Additional Shares of Rani Therapeutics Holdings Inc (RANI) - GuruFocus.com

Dec 10, 2024
pulisher
Dec 03, 2024

Rani Therapeutics stock hits 52-week low at $1.94 By Investing.com - Investing.com Nigeria

Dec 03, 2024
pulisher
Dec 02, 2024

Rani Therapeutics stock hits 52-week low at $1.94 - Investing.com India

Dec 02, 2024
pulisher
Nov 28, 2024

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $11.71 Average Target Price from Analysts - Defense World

Nov 28, 2024
pulisher
Nov 25, 2024

Brokerages Set Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Price Target at $11.71 - MarketBeat

Nov 25, 2024
pulisher
Nov 25, 2024

What is Zacks Small Cap’s Forecast for RANI FY2024 Earnings? - Defense World

Nov 25, 2024
pulisher
Nov 25, 2024

What is Zacks Small Cap's Forecast for RANI FY2024 Earnings? - MarketBeat

Nov 25, 2024
pulisher
Nov 20, 2024

RANI: Third Quarter Update - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

Rani Therapeutics' (RANI) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Nov 19, 2024
pulisher
Nov 18, 2024

Rani Therapeutics Advances in Biotherapeutics Market - TipRanks

Nov 18, 2024
pulisher
Nov 15, 2024

Rani Therapeutics Holdings Inc (RANI) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in Rani Therapeutics H - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update - The Manila Times

Nov 14, 2024
pulisher
Nov 14, 2024

Rani Therapeutics Slashes Q3 Loss by 31%, Secures $20M Funding for GLP-1 Development | RANI Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 07, 2024

Rani Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Nov 07, 2024
pulisher
Nov 03, 2024

Brokerages Set Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) PT at $11.71 - Defense World

Nov 03, 2024
pulisher
Oct 25, 2024

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Sees Significant Growth in Short Interest - MarketBeat

Oct 25, 2024
pulisher
Oct 23, 2024

Allied Gaming & Entertainment And 2 Other US Penny Stocks To Watch - Simply Wall St

Oct 23, 2024
pulisher
Oct 22, 2024

RANI: New Triagonist Data in Weight Loss - Zacks Small Cap Research

Oct 22, 2024
pulisher
Oct 19, 2024

Rani Therapeutics shares hold buy rating on positive preclinical data By Investing.com - Investing.com Australia

Oct 19, 2024
pulisher
Oct 19, 2024

Rani Therapeutics stock gets positive outlook from H.C. Wainwright after novel obesity candidate progress - Investing.com Australia

Oct 19, 2024
pulisher
Oct 19, 2024

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.75% - MSN

Oct 19, 2024
pulisher
Oct 18, 2024

Rani Therapeutics shares hold buy rating on positive preclinical data - Investing.com

Oct 18, 2024
pulisher
Oct 18, 2024

Rani Therapeutics (NASDAQ:RANI) Receives "Buy" Rating from HC Wainwright - MarketBeat

Oct 18, 2024

Rani Therapeutics Holdings Inc (RANI) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Rani Therapeutics Holdings Inc (RANI) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Imran Talat
Chief Executive Officer
Dec 09 '24
Buy
1.94
10,296
19,974
494,751
South Cone Investments Limited
10% Owner
Oct 15 '24
Sale
2.65
3,829,360
10,141,674
8,302,194
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
大文字化:     |  ボリューム (24 時間):